An interventional study of Lumoral Treatment in Periodontitis Chronic Generalized Moderate and Periodontitis Chronic Generalized Severe, sponsored by Koite Health Oy. Completed at 1 site in Lithuania. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-03-19.
Sponsored by Koite Health Oy · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study is designed to determine the efficacy of the Lumoral method in chronic periodontitis with a targeted group of stage III and IV periodontitis.
Improved supragingival plaque control can help to also sustain the subgingival plaque management in the long term.
In addition, the method might have a photobiomodulation effect on periodontal tissues.
The Lumoral Treatment is a CE-marked medical device developed to provide a potent, targeted antibacterial action on dental plaque in a home environment. The device mechanism of action is antibacterial photodynamic therapy (aPDT). The device is used by swishing a specially designed mouth rinse that strongly adheres to dental plaque. The plaque-adhered photoactive mouth rinse can be activated by a simple-to-use light applicator. Preliminary results have shown promising anti-inflammatory responses in addition to plaque reduction.
1,242 studies on the registry are indexed under Periodontitis; 304 are open to participants now.
This study's enrollment of 56 is above the median of 44 across 850 interventional studies indexed under Periodontitis.
Browse Periodontitis studies →Koite Health Oy is the lead sponsor of 14 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A complete clinical intraoral examination shall be performed for all subjects. Same demographic and clinical data will be obtained from subjects in both arms. The study group shall receive the Lumoral treatment -device, Lumorinse -tablets and instructions for their use. All subjects shall receive standard oral hygiene instructions for the use of an electric toothbrush, interdental brush, and dental floss.
Device: Lumoral Treatment
A complete clinical intraoral examination shall be performed for all subjects. Same demographic and clinical data will be obtained from subjects in both arms. All subjects shall receive standard oral hygiene instructions for the use of an electric toothbrush, interdental brush, and dental floss.
The Lumoral treatment -device is a CE-marked antibacterial home-use device for the treatment and prevention of oral diseases caused by bacteria. It is used in combination with a CE-marked mouth rinse called Lumorinse.
Bleeding on probing (BOP)
Improvement in bleeding on probing (BOP) * A full-mouth assessment at six sites per tooth (mesiobuccal, buccal, distobuccal, mesiolingual, lingual, distolingual) * Gingival bleeding is considered as positive if bleeding occurs within 15 seconds after gentle probing with a probe at the sulcus * Dichotomous scoring to each site of the tooth as bleeding "1 present" and "0 absent" * BOP is reported as the percentage (%) of sites with positive findings * Calculation formula: number of bleeding sites/ 6 times number of teeth
Time frame: 6 months
Active matrix metalloproteinase 8 (aMMP-8)
Change in periodontal inflammation marker aMMP-8
Time frame: 6 months
Visible plaque index (VPI)
Change in visible plaque index (VPI)
Time frame: 6 months
Probing pocket depth (PPD)
Change in probing pocket depth (PPD)
Time frame: 6 months
Clinical attachment level (CAL)
Change in clinical attachment level (CAL)
Time frame: 6 months
Deep periodontal pockets (over 4 mm)
Change in the number of deep periodontal periodontal pockets (over 4 mm)
Time frame: 6 months
Periodontal microbiological flora
Change in periodontal microbiological flora during the study period
Time frame: 6 months
Additional visits
Number of additional visits due to periodontitis status between 2nd and 3rd follow-up visits
Time frame: 6 months
OHIP-14
Patient related objectives: Oral-related quality of life measurement (OHIP-14) questionnaire
Time frame: 6 months
Device-related adverse event
Absence of device-related serious adverse events or any patterns of device-related adverse events graded as moderate
Time frame: 6 months
Plan to share: No — The IPD will only be administered by the researchers that are listed in the CIP.
Ran from Jun 2023 to primary completion in Dec 2025, 30 months.
Of 498 interventional studies with no phase under Periodontitis, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 31. This study's 30 months is above that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Koite Health Oy